Form 4: Edwards Lifesciences Executive Reports Stock Disposal to Cover Tax Obligations
SEC Form 4 Filing
Donald E. Bobo Jr., CVP of Strategy/Corporate Development at Edwards Lifesciences, disposed of 816 shares of common stock on May 11, 2025, to cover tax obligations.
Summary
- On May 11, 2025, Donald E. Bobo Jr., CVP of Strategy/Corporate Development at Edwards Lifesciences Corp, disposed of 816 shares of common stock.
- The transaction was executed at a price of $73.68 per share.
- The disposal was related to covering tax obligations.
- Following the transaction, Bobo directly owns 52,926.3707 shares of common stock.
- Bobo also indirectly owns 38,817.6991 shares through a 401(k) and 135,152 shares through a trust.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing a stock disposal for tax purposes, which is a neutral event.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. Disposals to cover tax obligations are common and don't necessarily indicate a negative outlook on the company.
Stakeholder Impact
- The transaction is unlikely to have a significant impact on shareholders, as it is a routine disposal of shares by an executive to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 05/11/2025 | Date of stock disposal transaction |
| 05/12/2025 | Date of signature by Attorney-in-Fact |
Keywords
Form 4, Beneficial Ownership, Stock Disposal, Edwards Lifesciences, Bobo, Executive, Tax Obligations, EW
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.